ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls”

January 11, 2013

Receipt Dates Clarified For AIDS-Cancers PA

July 4, 1997

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

September 13, 2002

Sharfstein To Leave FDA

January 7, 2011